Precise "cutting off" of tumors: a minimally invasive revolution
For patients with solid tumors who cannot undergo surgery or seek rapid recovery, traditional treatments are often accompanied by huge trauma or systemic side effects. Guangzhou R&F Hospital Cancer Center has introduced the world's leading transarterial embolization (TAE/TACE), with the core of "precisely blocking tumor blood supply and targeted killing of cancer cells", providing international patients (especially those in Southeast Asia and the Middle East) with an efficient and minimally invasive new anti-cancer option.
What is transarterial embolization?
Transarterial embolization is a minimally invasive technique that "starves tumors to death". Under the guidance of DSA (digital subtraction angiography), the doctor punctures the femoral artery (only 2mm incision) to the tumor blood supply artery and injects embolic agents (such as drug-loaded microspheres, iodized oil) to block blood flow. The tumor necroses due to ischemia and hypoxia, while the surrounding normal tissues are almost undamaged. If combined with chemotherapy drugs (i.e. TACE), the double blow of "cutting off food + poisoning" can be achieved simultaneously, and the efficacy is increased by 2-3 times. Completed under awake local anesthesia, leaving only tiny pinholes on the skin.
Arterial interventional operation process
Angiography pathfinding
✓ Needle eye incision at the root of the thigh (smaller than a grain of rice)
✓ Catheter goes directly to the liver tumor along the blood vessel (real-time X-ray navigation)
Accurate delivery of ammunition
✓ Infusion of high-concentration chemotherapy drugs (8 times more effective)
✓ Injection of embolic microspheres (blocking tumor blood supply)
Intelligent retreat
✓ Catheter withdrawal without leaving a trace (no need for suturing)
✓ Eating 6 hours after surgery
Which patients are suitable for this technology?
Interventional embolization is particularly suitable for the following situations:
Advanced liver cancer: tumor diameter ≤5cm or multiple nodules cannot be surgically removed;
Metastatic tumors: such as liver metastasis of colorectal cancer and bone metastasis of renal cancer;
Tumors with rich blood supply: such as hepatic hemangioma and uterine fibroids;
Elderly or combined with cirrhosis: patients who cannot tolerate open surgery.
Compared with traditional treatment, it has significant advantages
Treatment method | Traumatic | Recovery period | Side effects | Applicable population |
Traditional surgical resection | Large (laparotomy required) | 2-4 weeks | Liver function damage, bleeding risk | Localized tumor and good physical condition |
Systemic chemotherapy | Non-invasive | Multiple cycles | Hair loss, decreased immunity | Widely applicable but poor tolerance |
Interventional embolization | Minimally invasive (only pinhole) | Get out of bed 24 hours after surgery and be discharged in 3 days | Mild fever, abdominal pain (controllable) | Applicable to patients with impaired liver function and multiple lesions |
Why choose Guangzhou R&F Hospital?
1. International technology leader:
Cooperating with the National Cancer Research Center of Japan, using drug-loaded microsphere embolization (DEB-TACE) technology, the drug release time is accurate to 72 hours, and the tumor necrosis rate is increased to 85%;
Equipped with the world's most advanced DSA equipment (Artis Q), the vascular resolution is 0.1mm, and the error is less than 1mm.
2. Painless management upgrade:
Preoperative local anesthesia combined with intravenous sedation, painless during the entire operation;
Targeted analgesia pump (PCA) is used after surgery, which can relieve discomfort by simply pressing a button and avoid opioid addiction.
3. Cross-cultural adaptability:
Provide halal-certified embolization materials (such as gelatin sponge) for Middle Eastern patients;
Customize postoperative herbal hot packs (such as Indonesian turmeric paste) for Southeast Asian patients to accelerate recovery.
4. Rich experience and data reference
Completed 1,273 transnational interventional surgeries (the farthest patient was from Morocco)
85% of patients can be discharged from the hospital within 24 hours
Drug-loaded microsphere technology has obtained 3 international patents
Guangzhou R&F Hospital International Cancer Center Real treatment cases
Patient background:
Name: Ali (UAE, 58 years old, hepatitis B cirrhosis and liver cancer)
Condition: 3 tumors (the largest is 6.8cm), Child-Pugh B grade
Special needs: need to maintain business negotiation ability, refuse open surgery
Treatment process:
Transradial artery approach
Accurate embolization of tumor blood vessels with drug-loaded microspheres
Video conference 4 hours after surgery, fly back to Dubai the next day
Follow-up results:
Tumor shrank to 2.3cm after 8 weeks
Liver function remained stable (albumin>35g/L)
Signed a $5 million contract during treatment
"This treatment allows me to protect the family honor while fighting cancer." - Ali
Other real cases using minimally invasive interventional embolization
Case 1: Liver cancer patient (Malaysia, 58 years old)
5.5cm liver cancer under the background of liver cirrhosis, with extremely high surgical risk. After receiving DEB-TACE treatment (drug-loaded microspheres + cisplatin), the tumor shrank to 2cm 3 months after surgery, AFP (alpha-fetoprotein) dropped from 1200ng/mL to 50ng/mL, and liver function remained normal.
Case 2: Colorectal cancer liver metastasis (Saudi Arabia, 45 years old)
Multiple metastatic lesions (8) in both livers, chemotherapy was ineffective. After fractionated TACE combined with targeted drugs, the metastatic lesions were necrotic and calcified 6 months later, CEA (carcinoembryonic antigen) returned to normal, and the patient returned to work.
Case 3: Uterine fibroids (Indonesia, 34 years old)
Fibroids caused severe anemia and refused hysterectomy. 3 months after interventional embolization, the volume of the fibroids shrank by 70%, hemoglobin rose to normal, and fertility was preserved.
For more patient stories, please click
Use precision technology to strive for more possibilities for life.
Guangzhou R&F Hospital Cancer Center opens the era of "survival without chemotherapy" for cancer patients and wins a lasting victory for life. If you or your family are facing the dilemma of cancer treatment, please contact Guangzhou R&F Hospital Cancer Center. We provide multilingual medical record consultation, contact us immediately to obtain an assessment of treatment qualifications.
Contact us:
email: rfcancercenter@gmail.com |
whatsapp: +86 18565157271
